1alpha,25-Dihydroxyvitamin D2
Grundinformationen
- CAS
60133-18-8- Standard-SMILES
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O- InChIKey
ZGLHBRQAEXKACO-XJRQOBMKSA-N- Summenformel
- C28H44O3
- Durchschnittliche Molmasse
- 428,6 g/mol
- Monoisotopische Masse
- 428,32904527
Überblick
1alpha,25-dihydroxyvitamin D2 is a hydroxycalciol that is vitamin D2 bearing additional hydroxy substituents at positions 1alpha and 25. It has a role as a bone density conservation agent, a nutraceutical and a human xenobiotic metabolite. It is a vitamin D, a seco-ergostane and a hydroxycalciol. It is functionally related to a vitamin D2.
Namen und Bezeichner
- Bevorzugter Name
- 1alpha,25-Dihydroxyvitamin D2
- IUPAC
- trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- Englischer Name
- 1(alpha) 25-Dihydroxyvitamin D2*
- Summenformel
- C28H44O3
- Molmasse
- 428.65
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
60133-18-8- PubChem CID
- 9547243
- DTXSID
DTXSID90429509- ChEMBL
CHEMBL4303615- ChEBI
CHEBI:86320- UNII
- 5RWP08OQ36
- EC Number
- 634-659-6
- Nikkaji
- J482.252H
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 4,9
- Polarare Oberfläche (TPSA)
- 60,7 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 5
- Schwere Atome
- 31
- Formalladung
- 0
- Komplexität
- 758
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Siedepunkt
- 577.7 · 577.7±50.0 °C(Predicted)
- Dichte
- 1.06 · 1.06±0.1 g/cm3(Predicted)
- Flammpunkt
- 14 ℃ · 14℃
- storage temp.
- -20 °C · -20°C
- Löslichkeit
- 1 mg/ml · Ethanol: 1 mg/ml
- pka
- 14.43 · 14.43±0.40(Predicted)
- Aggregatzustand
- Powder
- Farbe
- White to off-white
- Biologische Quelle
- synthetic
- BRN
- 5635017 · 5635017
- Stabilität
- Light sensitive, Temperature sensitive
- InChIKey
- ZGLHBRQAEXKACO-KYHOFSCESA-N
- SMILES
- [C@@H]1(O)C/C(=C/C=C2\CCC[C@@]3(C)[C@@]\2([H])CC[C@@H]3[C@H](C)/C=C/C(C)C(O)(C)C)/C(=C)[C@@H](O)C1
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301+H311 (97.5%): Toxic if swallowed or in contact with skin [Danger Acute toxicity, oral; acute toxicity, dermal]
P260, P262, P264, P270, P271, P280, P284, P301+P316, P302+P352, P304+P340, P316, P319, P320, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Gefahrenhinweise
Sicherheitsdaten
- F
- 8-10-19
- wgk
- 3
- ridadr
- UN 2811 6.1/PG 2
- risk_code
- 23/24/25-63-48/25-26-24/25-11
- hazard_code
- T,T+,F
- safety_code
- 36/37-45-28-16-7
- Speicherklasse
- 6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials
- Hazard Classifications
- Acute Tox. 2 InhalationAcute Tox. 3 DermalAcute Tox. 3 OralSTOT RE 1 Oral
Chemie und Industrie
Pharmakologische Informationen
Anwendungen
VerwendenThe active metabolite of Vitamin D2 (V676040).
Anbieter100 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A hydroxycalciol that is vitamin D2 bearing additional hydroxy substituents at positions 1alpha and 25.
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…